These findings suggested that carriers with AC and CC genotypes exhibit an adequate antihypertensive efficacy response to valsartan, and the C allele of AGTR1 A1166C may be an independent factor associated with good control of hypertension with valsartan treatment. Here, AGTR1 is linked to hypertensive disorder.